Literature DB >> 21377743

Microarray analysis of microRNA expression in LPS induced inflammation of human middle ear epithelial cells (HMEECs).

Jae-Jun Song1, Seong Keun Kwon, Chang Gun Cho, Seok-Won Park, Sung-Won Chae.   

Abstract

OBJECTIVES: The primary aim of this study was to reveal the relationship between inflammatory response of human middle ear epithelial cell (HMEEC) and microRNA (miRNA).
METHODS: In experimental group, cells were treated with lipopolysaccharide (LPS) for 2 h. No LPS was treated in the control group. Total RNA was extractedand used for miRNA microarray analysis. The predicted targets of miRNA with significant change were obtained using miRBase. To assess the function of predicted target gene lists, we evaluated the frequency of specific gene ontology (GO) terms among the predicted target genes of the miRNA with significant change using DAVID (Database for Annotation, Visualization and Integrated Discovery).
RESULTS: After normalization, the number of the differentially expressed genes was 15. Among them, 5 miRNAs were up-regulated and 10 miRNAs were down-regulated in LPS group compared with control group. The most enriched GO terms in the predicted target genes of miRNA with increased expression were developmental process, response to biotic stimulus, acute inflammatory response, and regulation of cell growth. The most enriched GO terms in the predicted target genes of miRNA with decreased expression were developmental process, cell differentiation, endocytosis, cell communication, IκB kinase/NFκB cascade, complement activation, innate immune response and cell adhesion.
CONCLUSIONS: In conclusion, we identified the differentially expressed miRNA in LPS induced acute inflammation of HMEECs whose expression profile may provide a useful clue for the understanding of pathophysiology of otitis media. Our work indicates that miRNA play important role in the pathogenesis of otitis media.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21377743     DOI: 10.1016/j.ijporl.2011.02.001

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  13 in total

Review 1.  Panel 5: Microbiology and immunology panel.

Authors:  Timothy F Murphy; Tasnee Chonmaitree; Stephen Barenkamp; Jennelle Kyd; Johanna Nokso-Koivisto; Janak A Patel; Terho Heikkinen; Noboru Yamanaka; Pearay Ogra; W Edward Swords; Tania Sih; Melinda M Pettigrew
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

2.  Nontypeable Haemophilus influenzae lysates increase heterogeneous nuclear ribonucleoprotein secretion and exosome release in human middle-ear epithelial cells.

Authors:  Stéphanie Val; Anna Krueger; Marian Poley; Ariella Cohen; Kristy Brown; Aswini Panigrahi; Diego Preciado
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

3.  A2ML1 and otitis media: novel variants, differential expression, and relevant pathways.

Authors:  Eric D Larson; Jose Pedrito M Magno; Matthew J Steritz; Erasmo Gonzalo D V Llanes; Jonathan Cardwell; Melquiadesa Pedro; Tori Bootpetch Roberts; Elisabet Einarsdottir; Rose Anne Q Rosanes; Christopher Greenlee; Rachel Ann P Santos; Ayesha Yousaf; Sven-Olrik Streubel; Aileen Trinidad R Santos; Amanda G Ruiz; Sheryl Mae Lagrana-Villagracia; Dylan Ray; Talitha Karisse L Yarza; Melissa A Scholes; Catherine B Anderson; Anushree Acharya; Samuel P Gubbels; Michael J Bamshad; Stephen P Cass; Nanette R Lee; Rehan S Shaikh; Deborah A Nickerson; Karen L Mohlke; Jeremy D Prager; Teresa Luisa G Cruz; Patricia J Yoon; Generoso T Abes; David A Schwartz; Abner L Chan; Todd M Wine; Eva Maria Cutiongco-de la Paz; Norman Friedman; Katerina Kechris; Juha Kere; Suzanne M Leal; Ivana V Yang; Janak A Patel; Ma Leah C Tantoco; Saima Riazuddin; Kenny H Chan; Petri S Mattila; Maria Rina T Reyes-Quintos; Zubair M Ahmed; Herman A Jenkins; Tasnee Chonmaitree; Lena Hafrén; Charlotte M Chiong; Regie Lyn P Santos-Cortez
Journal:  Hum Mutat       Date:  2019-05-21       Impact factor: 4.878

4.  Association of microRNA 146 with middle ear hyperplasia in pediatric otitis media.

Authors:  Tina L Samuels; Justin Yan; Pawjai Khampang; Alexander MacKinnon; Wenzhou Hong; Nikki Johnston; Joseph E Kerschner
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2016-07-02       Impact factor: 1.675

Review 5.  microRNAs: the art of silencing in the ear.

Authors:  Anya Rudnicki; Karen B Avraham
Journal:  EMBO Mol Med       Date:  2012-06-29       Impact factor: 12.137

6.  CEBPG Exhibits Allele-Specific Expression in Human Bronchial Epithelial Cells.

Authors:  Thomas M Blomquist; Ronald D Brown; Erin L Crawford; Ivana de la Serna; Kandace Williams; Youngsook Yoon; Dawn-Alita Hernandez; James C Willey
Journal:  Gene Regul Syst Bio       Date:  2013-07-04

Review 7.  MicroRNAs in sensorineural diseases of the ear.

Authors:  Kathy Ushakov; Anya Rudnicki; Karen B Avraham
Journal:  Front Mol Neurosci       Date:  2013-12-23       Impact factor: 5.639

8.  Purification and characterization of microRNAs within middle ear fluid exosomes: implication in otitis media pathophysiology.

Authors:  Stéphanie Val; Stephanie Jeong; Marian Poley; Anna Krueger; Gustavo Nino; Kristy Brown; Diego Preciado
Journal:  Pediatr Res       Date:  2017-02-03       Impact factor: 3.756

Review 9.  Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models.

Authors:  Jian-Dong Li; Ann Hermansson; Allen F Ryan; Lauren O Bakaletz; Steve D Brown; Michael T Cheeseman; Steven K Juhn; Timothy T K Jung; David J Lim; Jae Hyang Lim; Jizhen Lin; Sung-Kyun Moon; J Christopher Post
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

10.  Next-generation sequencing of small RNAs from inner ear sensory epithelium identifies microRNAs and defines regulatory pathways.

Authors:  Anya Rudnicki; Ofer Isakov; Kathy Ushakov; Shaked Shivatzki; Inbal Weiss; Lilach M Friedman; Noam Shomron; Karen B Avraham
Journal:  BMC Genomics       Date:  2014-06-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.